Early remission is a realistic target in a majority of patients with DMARD-naive rheumatoid arthritis

T Rannio, J Asikainen, A Kokko, P Hannonen… - The Journal of …, 2016 - jrheum.org
Objective. We analyzed remission rates at 3 and 12 months in patients with rheumatoid
arthritis (RA) who were naive for disease-modifying antirheumatic drugs (DMARD) and who …
被引用次数：25 相关文章

Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis

T Rannio, J Asikainen, A Kokko… - The Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective We analyzed remission rates at 3 and 12 months in patients with rheumatoid
arthritis (RA) who were naive for disease-modifying antirheumatic drugs (DMARD) and who …

Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis

T Rannio, J Asikainen, A Kokko, P Hannonen… - The Journal of …, 2016 - jrheum.org
Objective. We analyzed remission rates at 3 and 12 months in patients with rheumatoid
arthritis (RA) who were naive for disease-modifying antirheumatic drugs (DMARD) and who …

Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.

T Rannio, J Asikainen, A Kokko… - The Journal of …, 2016 - europepmc.org
Objective We analyzed remission rates at 3 and 12 months in patients with rheumatoid
arthritis (RA) who were naive for disease-modifying antirheumatic drugs (DMARD) and who …

Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis

T Rannio, J Asikainen, A Kokko, P Hannonen… - The Journal of …, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective.</jats: title>< jats: p> We analyzed remission rates at 3
and 12 months in patients with rheumatoid arthritis (RA) who were naive for disease …